Riskpilot← Back to searchSign inGet full accessWG Biotech ApS
APSActiveCVR 36940131Rungsted Strandvej 113Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2015— employees
Revenue 2025
DKK -7M
-115% vs 2024
EBITDA margin
1.6%
+28% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
DKK 2,2M
-96% vs 2024
| Revenue | DKK -7M | -115% |
| EBITDA | DKK -114K | +28% |
| Net profit | DKK 2,2M | -96% |
| Total assets | DKK 311,6M | -2% |
| Equity | DKK 311,6M | +1% |
| Employees | — | — |
Legal name
WG Biotech ApS
CVR number
36940131
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
26. juni 2015
Share capital
DKK 109.948
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør.
Company purpose
Selskabets formål er at eje kapitalandele i andre selskaber indenfor biotek branchen.
Address
Rungsted Strandvej 113
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | -915.846 | -302.272 | 48.499 | 45.114 | -6.963 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -58 | -88 | -42 | 657.638 | 389.630 | 502.827 | -134 | -33 | -142 | -159 | -114 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -58 | -88 | -42 | 657.638 | 389.630 | 502.827 | -134 | -33 | -142 | -159 | -114 |
| Net financials | 0 | -181 | -183 | 657.475 | 389.475 | 502.655 | -913.726 | -300.200 | 52.616 | 48.693 | 2.280 |
| Profit before tax | -58 | -269 | -225 | 657.450 | 389.441 | 502.621 | -913.860 | -300.233 | 52.474 | 48.534 | 2.166 |
| Tax | -9 | -4 | -5 | -9 | -41 | -0 | -0 | -0 | 3.600 | -0 | -0 |
| Net profit | -49 | -265 | -220 | 657.459 | 389.482 | 502.621 | -913.860 | -300.233 | 48.874 | 48.534 | 2.166 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6.747 | 6.728 | 6.708 | 664.357 | 1.149.178 | 1.652.037 | 510.981 | 211.025 | 273.220 | 318.736 | 311.635 |
| Equity | 61 | -204 | -425 | 657.034 | 1.141.674 | 1.644.295 | 503.084 | 202.851 | 260.908 | 309.442 | 311.608 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6.686 | 6.932 | 7.133 | 7.323 | 7.504 | 7.742 | 7.897 | 8.174 | 12.312 | 9.294 | 27 |
| Total debt | 6.686 | 6.932 | 7.133 | 7.323 | 7.504 | 7.742 | 7.897 | 8.174 | 12.312 | 9.294 | 27 |
EBITDA margin
-11400000.0%
This company
15.8%
Market median
-72151999% vs market
20152025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20152025
Return on equity
0.7%
This company
18.4%
Market median
-96% vs market
20152025
Net profit margin
216600000.0%
This company
8.1%
Market median
+2674073974% vs market
20152025
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20152025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20152025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-06-26 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JE Management | Management | 2015 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
WECO A/S | Company | 66.7% | 66.7% | 2025 |
WG Biotech ApS | Company | 15.0% | 15.0% | 2021 |
| Individual | 15.0% | 15.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
WECO A/S
WG Biotech ApS Board members of WG Biotech ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Ernst Wedell-Wedellsborg | Management | 0 companies |